Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
TACE combined with MTT and PD-(L)1 demonstrated better outcomes for patients with liver cancer and lung metastases compared to MTT and PD-(L)1 alone, without increasing complication rates, suggesting a promising first-line treatment option.
Authors
- Junjie Lu (ORCID: https://orcid.org/0000-0002-3757-6578)
- Yi Ding (ORCID: https://orcid.org/0000-0002-2158-3108)
- Wei Peng (ORCID: https://orcid.org/0000-0002-1604-5110)
- Xiaoli Yang (ORCID: https://orcid.org/0000-0003-4283-9667)
- Yongfa Liu (ORCID: https://orcid.org/0000-0002-5657-9600)
- Xiang Chen (ORCID: https://orcid.org/0000-0003-2374-0020)
- Jin Yang (ORCID: https://orcid.org/0000-0001-9625-7449)
- Bo Li (ORCID: https://orcid.org/0009-0001-4607-5329)
Institutions
- Sichuan University (CN)
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/jhc.s509120
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00